Welcome to LookChem.com Sign In|Join Free

CAS

  • or

955929-58-5

Post Buying Request

955929-58-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

955929-58-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 955929-58-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,5,5,9,2 and 9 respectively; the second part has 2 digits, 5 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 955929-58:
(8*9)+(7*5)+(6*5)+(5*9)+(4*2)+(3*9)+(2*5)+(1*8)=235
235 % 10 = 5
So 955929-58-5 is a valid CAS Registry Number.

955929-58-5Relevant articles and documents

Efficient cross-coupling of aryl/alkenyl triflates with acyclic secondary alkylboronic acids

Si, Tengda,Li, Bowen,Xiong, Wenrui,Xu, Bin,Tang, Wenjun

supporting information, p. 9903 - 9909 (2017/12/12)

Aryl-secondary alkyl cross-coupling with aryl sulfonate esters as coupling partners remains a significant challenge. Efficient cross-coupling between aryl/alkenyl triflates and acyclic secondary alkylboronic acids is realized for the first time to provide a series of sterically congested acyclic secondary alkyl arenes/olefins in good to excellent yields. The employment of sterically bulky P,PO ligand L1/L2 is crucial for the high yields and selectivities. The method has enabled a concise and 4-step synthesis of a key intermediate of male contraceptive agent and PAF antagonist gossypol.

NEW OXADIAZOLE DERIVATIVES

-

Page/Page column 37-38, (2011/10/10)

The present invention relates to an oxadiazole derivative of formula (I)1 or a pharmaceutically acceptable salt or N-oxide thereof: wherein, R1 represents a hydrogen atom, a C1-2 alkyl group or a C3-4 cycloalkyl-C1-2

New pyrazole derivatives

-

Paragraph 0119; 0120, (2013/03/26)

The present invention relates to a compound of formula (I), to the process for preparing such compounds and to their use in the treatment of a pathological condition or disease susceptible to amelioration by sphingosine-1-phosphate receptors (S1P1) agonists.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 955929-58-5